相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Hongjie Wang et al.
NATURE MEDICINE (2011)
Oncolytic (replication-competent) adenoviruses as anticancer agents
Karoly Toth et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Proximity ligation assays: a recent addition to the proteomics toolbox
Irene Weibrecht et al.
EXPERT REVIEW OF PROTEOMICS (2010)
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors
S. Pesonen et al.
GENE THERAPY (2010)
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood
A. Danielsson et al.
GENE THERAPY (2010)
Crosstalk between desmoglein-2/desmocollin-2/Src kinase and coxsackie and adenovirus receptor/ZO-1 protein complexes, regulates blood-testis barrier dynamics
Pearl P. Y. Lie et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Internalized Somatostatin Receptor Subtype 2 in Neuroendocrine Tumors of Octreotide-Treated Patients
Jean Claude Reubi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
Justyna Leja et al.
PLOS ONE (2010)
Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
Angela C. Bradshaw et al.
PLOS PATHOGENS (2010)
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
Robert C. Carlisle et al.
BLOOD (2009)
Mechanisms and Influence of Octreotide-Induced Regulation of Somatostatin Receptor 2 on Hepatocellular Carcinoma
Yun-Peng Hua et al.
CHEMOTHERAPY (2009)
BlobFinder, a tool for fluorescence microscopy image cytometry
A. Allalou et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2009)
Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors
Sergey S. Seregin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
The Influence of Innate and Pre-Existing Immunity on Adenovirus Therapy
Anne K. Zaiss et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region
A. Danielsson et al.
CANCER GENE THERAPY (2008)
Neuroendocrine tumors of the diffuse neuroendocrine system
Bjorn I. Gustafsson et al.
CURRENT OPINION IN ONCOLOGY (2008)
Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies
M. Sarkioja et al.
GENE THERAPY (2008)
The effect of transforming growth factor on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling
Frank P. Leu et al.
MOLECULAR CANCER RESEARCH (2008)
Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob
Hongjie Wang et al.
JOURNAL OF VIROLOGY (2007)
Neuroblastoma and other neuroendocrine tumors
Robert Howman-Giles et al.
SEMINARS IN NUCLEAR MEDICINE (2007)
A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
Justyna Leja et al.
CLINICAL CANCER RESEARCH (2007)
Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver
T. Au et al.
CANCER GENE THERAPY (2007)
Detection of individual microbial pathogens by proximity ligation
Sigrun M. Gustafsdottir et al.
CLINICAL CHEMISTRY (2006)
Current strategies and future directions for eluding adenoviral vector immunity
Dinesh S. Bangari et al.
CURRENT GENE THERAPY (2006)
Proximity ligation assays for sensitive and specific protein analyses
SM Gustafsdottir et al.
ANALYTICAL BIOCHEMISTRY (2005)
AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle
M Lie-A-Ling et al.
GENE THERAPY (2005)
Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2005)
Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism
M Nilsson et al.
MOLECULAR THERAPY (2004)
A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer
WS Cheng et al.
MOLECULAR THERAPY (2004)
Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model
V Tsai et al.
CLINICAL CANCER RESEARCH (2004)
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
K Öberg et al.
ANNALS OF ONCOLOGY (2004)
Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells
M Nilsson et al.
JOURNAL OF GENE MEDICINE (2004)
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus
A Kanerva et al.
MOLECULAR THERAPY (2003)
Structural basis for variation in adenovirus affinity for the cellular coxsackievirus and adenovirus receptor
J Howitt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells
M Kim et al.
EUROPEAN JOURNAL OF CANCER (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the Hl loop of their fiber knob
H Mizuguchi et al.
GENE THERAPY (2001)
分享论文
